Accessibility Menu
Ginkgo Bioworks Stock Quote

Ginkgo Bioworks (NYSE: DNA)

$12.67
(-3.5%)
-0.46
Price as of October 22, 2025, 3:58 p.m. ET

KEY DATA POINTS

Current Price
$12.78
Daily Change
(-3.5%) $0.46
Day's Range
$12.06 - $13.08
Previous Close
$12.78
Open
$12.78
Beta
2.41
Volume
1,560,759
Average Volume
1,713,730
Market Cap
737.9M
Market Cap / Employee
$13.13M
52wk Range
$5 - $17.58
Revenue
-
Gross Margin
0.53%
Dividend Yield
N/A
EPS
-$5.85
CAPs Rating
-
Industry
Life Sciences Tools and Services

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Ginkgo Bioworks Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
DNA+47.2%N/AN/A-97%
S&P+15.06%+95.03%+14.29%+62%

Ginkgo Bioworks Company Info

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. It operates through the Cell Programming/Foundry, and Biosecurity segments. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$49.60M-11.7%
Gross Profit$18.99M-24.5%
Gross Margin38.28%-6.5%
Market Cap$624.73M-2.3%
Market Cap / Employee$0.75M0.0%
Employees834-31.5%
Net Income-$60.30M72.2%
EBITDA-$52.62M60.5%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$214.52M-70.7%
Accounts Receivable$23.13M24.4%
Inventory00.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$428.83M-5.2%
Short Term Debt$0.00M0.0%

Ratios

Q2 2025YOY Change
Return On Assets-22.07%23.8%
Return On Invested Capital-71.86%6.1%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$40.29M63.8%
Operating Free Cash Flow-$40.25M52.3%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book0.480.620.410.9038.63%
Price to Sales1.952.331.302.67-28.26%
Price to Tangible Book Value0.540.680.461.0135.42%
Enterprise Value to EBITDA-7.32-4.99-3.10-10.67249.52%
Return on Equity-63.5%-60.3%-57.8%-43.6%-43.26%
Total Debt$445.59M$467.73M$434.56M$428.83M-5.18%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.